Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04083365
Title Capecitabine Plus Concomitant Radiation Therapy Followed by Durvalumab as Preoperative Treatment in Rectal Cancer (PANDORA)
Acronym PANDORA
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors AUSL Romagna Rimini
Indications
Therapies
Age Groups: senior | adult
Covered Countries ITA


No variant requirements are available.